Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NR1H2 | P55055 | 1/20 | 0.37 |
| ▸ | NR1H3 | Q13133 | 1/20 | 0.37 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.32 |
| ▸ | TSHR | P16473 | 2/20 | 0.31 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.31 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.31 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.31 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.31 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.31 |
| ▸ | LMNA | P02545 | 1/20 | 0.30 |
| ▸ | BLM | P54132 | 1/20 | 0.30 |
| ▸ | HTR7 | P34969 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7737512 | 0.79 | RXFP1 (0.33) | NR1H2NR1H3ALDH1A1LMNA | |
| SCHEMBL10941267 | 0.78 | NR1H2 (0.38) | NR1H2NR1H3ALDH1A1TSHR | |
| SCHEMBL10913604 | 0.78 | ALDH1A1 (0.39) | NR1H2NR1H3ALDH1A1TSHR | |
| SCHEMBL18796002 | 0.77 | NR1H2 (0.37) | NR1H2NR1H3ALDH1A1TSHR | |
| SCHEMBL2003493 | 0.74 | APOBEC3G (0.38) | NR1H2NR1H3ALDH1A1 | |
| SCHEMBL9179552 | 0.74 | ALDH1A1 (0.36) | NR1H2NR1H3ALDH1A1TSHRCYP1A2 | |
| SCHEMBL1147728 | 0.71 | NR1H2 (0.53) | NR1H2NR1H3ALDH1A1TSHRCYP2C19 | |
| SCHEMBL31168893 | 0.69 | ALDH1A1 (0.43) | ALDH1A1TSHRCYP1A2CYP2D6NFKB1 | |
| SCHEMBL3761218 | 0.69 | ALDH1A1 (0.43) | ALDH1A1TSHRCYP1A2CYP2D6NFKB1 | |
| SCHEMBL7737525 | 0.68 | NR1H2 (0.54) | NR1H2NR1H3ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8933276-B2 | Heterogeneous chiral catalyst | AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (SG) | 2015-01-13 | — | — | US | disclosed |
| EP-1973656-B1 | HETEROGENEOUS CHIRAL CATALYST | AGENCY SCIENCE TECH & RES (SG) | 2012-05-16 | — | — | EP | disclosed |
| US-20090281358-A1 | HETEROGENEOUS CHIRAL CATALYST | AGENCY FOR SCIENCE TECHNOLOGY AND RESEARCH (SG) | 2009-11-12 | — | — | US | disclosed |
| EP-1973656-A4 | HETEROGENEOUS CHIRAL CATALYST | AGENCY SCIENCE TECH & RES (SG) | 2009-08-05 | — | — | EP | disclosed |
| EP-1973656-A1 | HETEROGENEOUS CHIRAL CATALYST | Agency for Science, Technology and Research (SG) | 2008-10-01 | — | — | EP | disclosed |
| WO-2007084075-A1 | HETEROGENEOUS CHIRAL CATALYST | AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (SG) | 2007-07-26 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090281358-A1 | HETEROGENEOUS CHIRAL CATALYST | FDFT1, DCAF1, AGL | NR1H2 508/4885NR1H3 342/4885ALDH1A1 920/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.